Buy Jentadueto from Canada

$118.99

Jentadueto offers an advantage over monotherapy by combining two medications with different but complementary mechanisms of action. Linagliptin enhances the activity of incretins, hormones that reduce postprandial blood glucose levels. Metformin acts on the liver to reduce gluconeogenesis, thus lowering fasting blood glucose. Together, they help improve glycemic control without causing weight gain, a common side effect associated with some diabetes medications.

- +
SKU: N/A Category:

Description

Jentadueto is an oral medication used in the management of Type 2 diabetes. It combines two antihyperglycemic agents: linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride, a biguanide. Linagliptin works by increasing hormones that stimulate insulin release in response to high blood glucose levels, while metformin decreases glucose production by the liver and its absorption in the gut. This dual mechanism helps control blood sugar levels in Type 2 diabetes patients. Jentadueto is available in tablet form for administration.